A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease

PURPOSE: The purpose was to study the effect of hemodialysis (HD) on macular thickness in patients with diabetic retinopathy (DR) and end-stage renal disease. MATERIALS AND METHODS: In this prospective observational study, patients undergoing HD for diabetic nephropathy were recruited. None of the p...

Full description

Bibliographic Details
Main Authors: Shwetha Suryakanth, H N Ravi Shankar, Mallikarjun M Heralgi, Pradeep Sagar, V Kavitha, S Mahesha, N Suresh Babu, Pradeep Tekade
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=4;spage=367;epage=371;aulast=Suryakanth
_version_ 1818968256929595392
author Shwetha Suryakanth
H N Ravi Shankar
Mallikarjun M Heralgi
Pradeep Sagar
V Kavitha
S Mahesha
N Suresh Babu
Pradeep Tekade
author_facet Shwetha Suryakanth
H N Ravi Shankar
Mallikarjun M Heralgi
Pradeep Sagar
V Kavitha
S Mahesha
N Suresh Babu
Pradeep Tekade
author_sort Shwetha Suryakanth
collection DOAJ
description PURPOSE: The purpose was to study the effect of hemodialysis (HD) on macular thickness in patients with diabetic retinopathy (DR) and end-stage renal disease. MATERIALS AND METHODS: In this prospective observational study, patients undergoing HD for diabetic nephropathy were recruited. None of the patients received treatment for DR per se during the study duration. Patients underwent ocular examination and optical coherence tomography before HD and were followed up on day 3 and day 30. At each visit, central subfield macular thickness (CSMT) and total macular volume (TMV) were measured and compared with baseline values using analysis of variance and post hoc test (Wilcoxon's matched-pairs signed-rank test). RESULTS: Thirty-one eyes of 19 patients were recruited in the study. The mean CSMT decreased from baseline value of 278.93 ± 45.01 μ to 239.81 ± 40.54 μ at the end of 30 days (P < 0.005). The mean TMV decreased from baseline value of 8.14 ± 0.68 mm3 to 7.80 ± 0.63 mm3 on day 30 (P < 0.005). CONCLUSION: There was a statistically significant reduction in CSMT and TMV after HD at 30 days as compared to baseline values. HD alone results in reduction of macular thickness over short term.
first_indexed 2024-12-20T14:01:48Z
format Article
id doaj.art-c433712e11e94befb0df2c2c4acedd3a
institution Directory Open Access Journal
issn 2211-5056
2211-5072
language English
last_indexed 2024-12-20T14:01:48Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Taiwan Journal of Ophthalmology
spelling doaj.art-c433712e11e94befb0df2c2c4acedd3a2022-12-21T19:38:21ZengWolters Kluwer Medknow PublicationsTaiwan Journal of Ophthalmology2211-50562211-50722021-01-0111436737110.4103/tjo.tjo_86_20A study of effect of hemodialysis on macular thickness in patients with end-stage renal diseaseShwetha SuryakanthH N Ravi ShankarMallikarjun M HeralgiPradeep SagarV KavithaS MaheshaN Suresh BabuPradeep TekadePURPOSE: The purpose was to study the effect of hemodialysis (HD) on macular thickness in patients with diabetic retinopathy (DR) and end-stage renal disease. MATERIALS AND METHODS: In this prospective observational study, patients undergoing HD for diabetic nephropathy were recruited. None of the patients received treatment for DR per se during the study duration. Patients underwent ocular examination and optical coherence tomography before HD and were followed up on day 3 and day 30. At each visit, central subfield macular thickness (CSMT) and total macular volume (TMV) were measured and compared with baseline values using analysis of variance and post hoc test (Wilcoxon's matched-pairs signed-rank test). RESULTS: Thirty-one eyes of 19 patients were recruited in the study. The mean CSMT decreased from baseline value of 278.93 ± 45.01 μ to 239.81 ± 40.54 μ at the end of 30 days (P < 0.005). The mean TMV decreased from baseline value of 8.14 ± 0.68 mm3 to 7.80 ± 0.63 mm3 on day 30 (P < 0.005). CONCLUSION: There was a statistically significant reduction in CSMT and TMV after HD at 30 days as compared to baseline values. HD alone results in reduction of macular thickness over short term.http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=4;spage=367;epage=371;aulast=Suryakanthdiabetic nephropathydiabetic retinopathyhemodialysismacular edema
spellingShingle Shwetha Suryakanth
H N Ravi Shankar
Mallikarjun M Heralgi
Pradeep Sagar
V Kavitha
S Mahesha
N Suresh Babu
Pradeep Tekade
A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease
Taiwan Journal of Ophthalmology
diabetic nephropathy
diabetic retinopathy
hemodialysis
macular edema
title A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease
title_full A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease
title_fullStr A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease
title_full_unstemmed A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease
title_short A study of effect of hemodialysis on macular thickness in patients with end-stage renal disease
title_sort study of effect of hemodialysis on macular thickness in patients with end stage renal disease
topic diabetic nephropathy
diabetic retinopathy
hemodialysis
macular edema
url http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=4;spage=367;epage=371;aulast=Suryakanth
work_keys_str_mv AT shwethasuryakanth astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT hnravishankar astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT mallikarjunmheralgi astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT pradeepsagar astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT vkavitha astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT smahesha astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT nsureshbabu astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT pradeeptekade astudyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT shwethasuryakanth studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT hnravishankar studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT mallikarjunmheralgi studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT pradeepsagar studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT vkavitha studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT smahesha studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT nsureshbabu studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease
AT pradeeptekade studyofeffectofhemodialysisonmacularthicknessinpatientswithendstagerenaldisease